Summarized by Masters of Longevity from Longevity Technology.
A preview of a collaborative research program testing an encapsulated stem-cell approach for treating insulin-dependent diabetes, highlighting partners and study planning.
Key Takeaways
- Avaí Bio, Austrianova, and Ospedale San Raffaele will evaluate encapsulated stem cell-derived beta cells for insulin-dependent diabetes treatment.
- The collaboration will test Austrianova’s Cell-in-a-Box proprietary encapsulation platform with OSR’s stem cell-derived beta cells.
- The partners formed a joint steering committee and an Insulinova joint venture to coordinate the diabetes cell therapy program.
